pfizer semaglutide Pfizer's weight loss drug might be the new Ozempic, study suggests Pfizer struggles to catch up
Description
Most are mild to moderate
Beyond their impact on weight, these medications have shown promise in ameliorating obesity-related health markers, including lowering blood pressure, improving lipid profiles, and enhancing glycemic control (Marso et al., 2016)
A new @NatureMedicine review by @DanielJDrucker, a pioneer of this field.
We also report on two studies with findings that could bring eventual relief for patients still struggling with long COVID symptoms.
